Cheap generic GLP-1 India risks nutritional gap amid supplement quality crisis
India is expected to see a GLP-1 boom as Novo Nordisk’s semaglutide patent expires in the country this month. GLP-1s such as Wegovy and Ozempic have made a big impact in the treatment of diabetes and weight loss, especially in the US. The expiring patent marks an important moment for India’s pharmaceutical and nutritional sectors, … Read more